Pharmaceutical Technology

JULY 25, 2023

Boehringer Ingelheim and Eli Lilly have secured approval from the EC for Jardiance to treat adults with chronic kidney disease (CKD).

246

246

Bio Pharma Dive

JULY 25, 2023

The biotech’s leader Enrique Conterno is stepping down for personal reasons after a string of clinical setbacks that led to a restructuring. Eli Lilly veteran Thane Wettig will replace him in the interim.

130

130

Pharmaceutical Technology

JULY 25, 2023

The global pharmaceutical industry experienced a 20% increased in company filings sentiment in Q2 2023 compared with the previous quarter, according to GlobalData’s analysis.

130

130

Bio Pharma Dive

JULY 25, 2023

Shares fell as the biotech’s Dravet syndrome treatment missed investor expectations. But Stoke CEO Ed Kaye claims the company now better understands its drug and how to test it.

Drugs 130

Drugs 130

Advertisement

Clinical Supply

Pharmaceutical Technology

JULY 25, 2023

Astellas Pharma has entered a research partnership and licence agreement with PeptiDream for the discovery of new targeted protein degraders.

Protein 130

Protein Research 130

Bio Pharma Dive

JULY 25, 2023

CEO Chris Viehbacher described the restructuring, which will trim $1 billion in operating expenses, as a “complete redesign of Biogen.

130

130

Drug Discovery World

JULY 25, 2023

DDW’s Megan Thomas spoke with Frédéric Triebel , the French immunologist/oncologist who is best known for his 1990 discovery of the LAG-3 immune control mechanism. Triebel shares insights from his career, expands on his experience with the company he founded, Immutep, and comments on the future of immuno-oncology (I-O). Background Lymphocyte-activation gene 3, or LAG-3, is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T-cell function.

Immune Response 98

Immune Response Gene Protein Antibody 98

Pharmaceutical Technology

JULY 25, 2023

Mirum has received approval from the Health Canada for LIVMARLI to treat cholestatic pruritus in patients with Alagille syndrome.

130

130

Pharma Marketing Network

JULY 25, 2023

In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.

Marketing 98

Marketing Engineer Branding Research 98

Pharmaceutical Technology

JULY 25, 2023

Gilead Sciences and IT company Cognizant have announced an expansion of their collaboration to expedite digital transformation.

130

130

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Outsourcing Pharma

JULY 25, 2023

Adherence specialist AARDEX Group has been announced as a founding member of the CancerX initiative, which aims to bring diverse stakeholders together to drive innovation and improve follow up for cancer patients.

Regulation 98

Regulation Marketing 98

Pharmaceutical Technology

JULY 25, 2023

The EMA CHMP has provided a positive opinion recommending grant of marketing authorisation to ViiV Healthcare’s cabotegravir.

Marketing 130

Marketing 130

Outsourcing Pharma

JULY 25, 2023

H.E.L Group (H.E.L), a global developer and manufacturer of laboratory tools, has signed an agreement with the Indian Institute of Technology Kanpur (IIT Kanpur), a prestigious Indian academic institution kickstarting scientific and technological research.

Manufacturing 98

Manufacturing Development Research Regulation 98

Pharmaceutical Technology

JULY 25, 2023

Golgi Neurosciences has joined forces with Breye Therapeutics for the development of a P2X7 receptor antagonist programme.

Development 130

Development 130

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

XTalks

JULY 25, 2023

Emergent BioSolutions, a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, has achieved a significant milestone with the approval of its Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) vaccine by the US Food and Drug Administration (FDA). The FDA has granted approval for the use of Cyfendus in post-exposure prophylaxis against disease following suspected or confirmed exposure to Bacillus anthracis in individuals aged 18 to 65 years.

FDA Approval 98

FDA Approval Vaccination Vaccine Antibody 98

Pharmaceutical Technology

JULY 25, 2023

ImmunoGen has signed agreement with ImmunoBiochem for the development of next-generation antibody-drug conjugates (ADCs).

Development 130

Development Antibody Drugs 130

XTalks

JULY 25, 2023

Quidel Cardiovascular Inc. (QuidelOrtho) recently issued a recall for its Quidel Triage Cardiac Panels, citing a potential risk of false negative troponin results. The company took this measure to address the issue and prioritize patient safety. False negative troponin results could lead to delayed diagnosis or missing a potentially life-threatening myocardial infarction.

Production 98

Production Doctors Doctor Containment 98

Pharmaceutical Technology

JULY 25, 2023

The global pharmaceutical industry recorded a 5% drop in big data hiring activity in Q2 2023, according to GlobalData

Big Data 130

Big Data 130

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Pharma Marketing Network

JULY 25, 2023

Ads Manager is a powerful platform that can help pharma companies reach their target audience and achieve their marketing goals. One of the ways to do this is to customize your audience. This means targeting your ads to people who are most likely to be interested in your products or services. Here are some tips for customizing your audience in Ads Manager for the pharma industry: Use demographics: You can target your ads based on demographics, such as age, gender, location, and interests.

Marketing 98

Marketing Production Pharma Companies Branding 98

Pharmaceutical Technology

JULY 25, 2023

Partnerships, mergers, business combinations, and acquisitions could all be on the horizon for the biotech.

130

130

Drug Patent Watch

JULY 25, 2023

In a recent article published by IAM Magazine, titled “Why Pharma Companies Should File Patents Later In The R&D Process,” Alexander R. Trimble, PhD, a prominent patent attorney, explores the… The post Filing Strategies for Maximizing Pharma Patents appeared first on DrugPatentWatch - Make Better Decisions.

Pharma Companies 98

Pharma Companies 98

BioSpace

JULY 25, 2023

The Phase III trial, which will test the companies' mRNA-based personalized cancer vaccine and Merck’s blockbuster Keytruda checkpoint inhibitor, is slated for completion by the fall of 2029.

Vaccination 97

Vaccination Vaccine Trials 97

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Clinical Supply

Pharma Marketing Network

JULY 25, 2023

Google Ads is a great way to reach a wider audience for your pharma business. However, if you want to get the most out of your Google Ads campaigns, you need to optimize them for SEO. Here are some tips on how to increase SEO on Google Ads for the pharma industry: Use relevant keywords: When you’re creating your Google Ads campaigns, make sure to use relevant keywords.

Marketing 97

Marketing Drugs Production 97

Pharma Times

JULY 25, 2023

The company will utilise Qureight’s AI technology to undergo studies across a variety of complex lung diseases - News - PharmaTimes

Research 102

Research 102

Pharma Marketing Network

JULY 25, 2023

Traditionally, pharmaceutical companies have relied on demographics to target their marketing efforts. This means that they have focused on reaching consumers based on factors such as age, gender, income, and location. While demographics can be a useful starting point, they are not always enough to create effective marketing campaigns. This is because consumers are not just defined by their demographics.

Marketing 96

Marketing Compliance Branding Sales 96

Pharmaceutical Commerce

JULY 25, 2023

With FDA’s compliance deadline only three months away, the tech-supply chain partnership is expected to help manufacturers and wholesalers meet the Nov. 27 deadline.

Compliance 98

Compliance Manufacturing 98

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

XTalks

JULY 25, 2023

Amazon One, the revolutionary palm-scanning payment technology from Amazon, is set to expand significantly across the US. The retail giant recently announced plans to implement the technology in over 500 Amazon-owned Whole Foods Market stores nationwide by the end of the year. They payment system enables customers to make purchases by simply hovering their palm over a reader device, which identifies their unique palm signature and charges the purchase to the customer’s payment card on fil

Marketing 94

Marketing 94

Fierce Pharma

JULY 25, 2023

In reporting its first-quarter earnings, Biogen said it would halt the development of at least four investigational drugs to allow the company to focus on more lucrative opportunities. | In a sizable cost-cutting measure, Biogen will lay off 1,000 employees by 2025, it announced in presenting its second quarter earnings. With the company starting 2023 with 8,725 employees, that’s an 11.5% reduction of the workforce.

Development 92

Development Drugs 92

Outsourcing Pharma

JULY 25, 2023

Predictive Oncology is moving its corporate headquarters to its main laboratory facility in Pittsburgh, PA, a global life sciences hub.

Life Science 98

Life Science Regulation Marketing 98

Fierce Pharma

JULY 25, 2023

Patients with the eyelid disease Demodex blepharitis can now see a cure in Tarsus Pharmaceuticals’ Xdemvy, the first FDA-approved treatment for an ailment that affects some 25 million Americans.

FDA Approval 89

FDA Approval 89

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Clinical Supply